Literature DB >> 27596328

Beneficial properties of Passiflora caerulea on experimental colitis.

M L Anzoise1, C Marrassini2, H Bach3, S Gorzalczany4.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Passiflora caerulea L. (Passifloraceae) is a medicinal plant commonly used in traditional medicine in South America for different pathologies associated with the gastrointestinal tract. AIM OF THE STUDY: In the present study, the activity of the ethanolic extract of P. caerulea on an experimental colitis model related to inflammatory bowel disease has been investigated.
MATERIALS AND METHODS: Colitis was induced by intracolonic instillation of a 2mL of 4% (v/v) acetic acid solution. Macroscopic scoring, myeloperoxidase activity and thiobarbituric acid reactive substances levels were evaluated on isolated colon mucosae. The histopathological studies of colon mucosae were performed by hematoxylin and eosin and Alcian blue staining. Diarrhoea was induced by the administration of castor oil (0.3mL/mouse). The first watery defecation time, the total amount of solid, semi-solid and watery stools and the amount of watery stools were determined. The effect of the extract on a cumulative concentration-response curve of acetylcholine and CaCl2 on isolated rat jejunum was also evaluated. The phytochemical analysis was performed.
RESULTS: The extract (250mg/kg, p.o.) induced a significant reduction in the weight/length ratio, the macroscopic lesion score, TBARS levels and the microscopic tissue damage when compared with the acetic acid-treated group of animals. P. caerulea (125mg/kg, p.o.) decreased significantly the amount of watery stools in the castor oil-induced-diarrhoea model. Moreover, the P. caerulea extract antagonized the jejunum contractions induced by Ach (Emax for 0.3mg/mL: 76.25%; Emax for 1mg/mL: 63.47%; Emax for 3mg/mL: 42.01%) and CaCl2 (Emax for 0.3mg/mL: 75.69%; Emax for1 mg/mL: 56.1%; Emax for 3mg/mL: 53.4%). Isoorientin, vitexin, isovitexin, and vicenin-2 were identified in the extract.
CONCLUSION: P. caerulea showed anti-inflammatory, anti-diarrhoeal and spasmolityc activities on preclinical models.
Copyright © 2016. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Anti-inflammatory; Antioxidant activity; Antispasmodic; Histological study; Passiflora caerulea; Ulcerative colitis model

Mesh:

Substances:

Year:  2016        PMID: 27596328     DOI: 10.1016/j.jep.2016.09.002

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  3 in total

1.  Keratin 1 maintains the intestinal barrier in ulcerative colitis.

Authors:  Jing Wu; Junkun Niu; Maojuan Li; Yinglei Miao
Journal:  Genes Genomics       Date:  2021-09-25       Impact factor: 1.839

2.  Extraction Processes with Several Solvents on Total Bioactive Compounds in Different Organs of Three Medicinal Plants.

Authors:  Nour El Houda Lezoul; Mohamed Belkadi; Fariborz Habibi; Fabián Guillén
Journal:  Molecules       Date:  2020-10-13       Impact factor: 4.411

3.  Effects of Foliar Treatment with a Trichoderma Plant Biostimulant Consortium on Passiflora caerulea L. Yield and Quality.

Authors:  Tatiana Eugenia Şesan; Anca Olguța Oancea; Laura Mihaela Ştefan; Vasile Sorin Mănoiu; Marius Ghiurea; Iuliana Răut; Diana Constantinescu-Aruxandei; Agnes Toma; Simona Savin; Adriana Florina Bira; Cristian Mihai Pomohaci; Florin Oancea
Journal:  Microorganisms       Date:  2020-01-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.